MedTrace Logo

SouthErn China REgisTry for Stroke on Traditional Chinese Medicine

NCT03380481 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2018-03-08

No results posted yet for this study

Summary

Stroke is the first most common cause of death in China and one of the major causes of functional disability in the adult population.The burden of stoke is significantly increased in China in recent years.

In order to investigate the prognosis of stroke, with diagnostic and treatment information of traditional Chinese medicine (TCM), and assess the effectiveness and safety of TCM for stroke in southern China, the investigators will conduct this multicenter prospective registry study in southern China. This study will recruit 10,000 consecutive eligible patients with acute stroke from more than 50 hospitals. 24 months follow-up will be carried out on-site in hospitals and by telephone to track endpoint (including all-cause mortality, composite cerebrovascular and cardiovascular events at one and two year follow up, and neurological and functional assessments).

Conditions

  • Stroke
  • Cerebral Infarction
  • Transient Ischemic Attack
  • Cerebral Hemorrhage
  • Subarachnoid Hemorrhage

Interventions

OTHER

observational only-no intervention

Observational only and no predesigned interventions in this study.

Sponsors & Collaborators

  • Yefeng Cai

    lead OTHER

Principal Investigators

  • Yefeng Cai, M.D.,Ph D · Guangdong Provincial Hospital of Traditional Chinese Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-15
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03380481 on ClinicalTrials.gov